Милвексан (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Милвексан" in Russian language version.

refsWebsite

Global rank Russian rank

4^th place

6^th place

2^nd place

3^rd place

doi.org

Fredenburgh, J. C., & Weitz, J. I. (2021). Factor XI as a target for new anticoagulants. Hämostaseologie, 41(02), 104-110. PMID 33860518 doi:10.1055/a-1384-3715
Weitz, J. I., Strony, J., Ageno, W., Gailani, D., Hylek, E. M., Lassen, M. R., ... & Raskob, G. E. (2021). Milvexian for the Prevention of Venous Thromboembolism. New England Journal of Medicine. doi:10.1056/NEJMoa2113194 PMID 34780683
Preis, M., Hirsch, J., Kotler, A., Zoabi, A., Stein, N., Rennert, G., & Saliba, W. (2017). Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events. Blood, The Journal of the American Society of Hematology, 129(9), 1210-1215. PMID 28039189 doi:10.1182/blood-2016-09-742262

Fredenburgh, J. C., & Weitz, J. I. (2021). Factor XI as a target for new anticoagulants. Hämostaseologie, 41(02), 104-110. PMID 33860518 doi:10.1055/a-1384-3715
Weitz, J. I., Strony, J., Ageno, W., Gailani, D., Hylek, E. M., Lassen, M. R., ... & Raskob, G. E. (2021). Milvexian for the Prevention of Venous Thromboembolism. New England Journal of Medicine. doi:10.1056/NEJMoa2113194 PMID 34780683
Preis, M., Hirsch, J., Kotler, A., Zoabi, A., Stein, N., Rennert, G., & Saliba, W. (2017). Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events. Blood, The Journal of the American Society of Hematology, 129(9), 1210-1215. PMID 28039189 doi:10.1182/blood-2016-09-742262